Patel Naimish sold CRSP
May 29, 2026 · Form 4 insider transaction
Patel Naimish sold 3,786 shares of CRISPR Therapeutics AG at $55.62 per share, a transaction worth $210.6K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Disposed (sell-side)
Shares
3,786
Price
$55.62
Total value
$210.6K
InsiderPatel Naimish
RoleOfficer
SecurityCommon Shares
Transaction codeS: Open-market sale
Transaction dateMay 29, 2026
Filing dateJune 1, 2026
Shares owned after19,357
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person.